2024 |
Agios Pharmaceuticals Inc
|
Independent Director |
426.3 K |
-0.8 % |
2024 |
Editas Medicine Inc
|
Independent Director |
144.8 K |
-32.0 % |
2024 |
Carisma Therapeutics Inc
|
Director |
- |
- |
2023 |
Agios Pharmaceuticals Inc
|
Independent Director |
429.8 K |
0.6 % |
2023 |
Editas Medicine Inc
|
Independent Director |
213.1 K |
-16.4 % |
2022 |
Agios Pharmaceuticals Inc
|
Independent Director |
427.3 K |
0.6 % |
2022 |
Editas Medicine Inc
|
Independent Director |
255.0 K |
-13.5 % |
2021 |
Agios Pharmaceuticals Inc
|
Independent Director |
424.9 K |
-0.0 % |
2021 |
Editas Medicine Inc
|
Independent Director |
294.7 K |
18.9 % |
2020 |
Agios Pharmaceuticals Inc
|
Independent Director |
425.0 K |
0.0 % |
2020 |
Editas Medicine Inc
|
Independent Director |
247.9 K |
-33.1 % |
2019 |
Agios Pharmaceuticals Inc
|
Independent Director |
424.9 K |
-22.4 % |
2019 |
Editas Medicine Inc
|
Independent Director |
370.7 K |
- |
2018 |
Agios Pharmaceuticals Inc
|
Director |
547.3 K |
-33.7 % |
2018 |
Editas Medicine Inc
|
Independent Director |
- |
- |
2017 |
Agios Pharmaceuticals Inc
|
Director |
825.5 K |
- |